Inhibitory effects of kanamycin on glycolysis in cochlea and kidney-possible involvement in the formation of oto- and nephrotoxicities.
D000818:Animals; D001921:Brain / Q000201:enzymology; D002245:Carbon Dioxide / Q000378:metabolism; D003051:Cochlea / Q000201:enzymology / Q000378:metabolism*; D005128:Eye Diseases / Q000139:chemically induced*; D005947:Glucose / Q000378:metabolism; D006019:Glycolysis / Q000187:drug effects*; D006168:Guinea Pigs; D007612:Kanamycin / Q000378:metabolism / Q000494:pharmacology*; D007668:Kidney / Q000378:metabolism*; D007674:Kidney Diseases / Q000139:chemically induced*; D008099:Liver / Q000201:enzymology; D010498:Perilymph / Q000378:metabolism
D002245:Carbon Dioxide; D007612:Kanamycin; D005947:Glucose